CA-SRIJAN/MATERIAL
Srijan, the technology and engineering division for Material, a global strategy and customer experience transformation consultancy, is proud to announce it has been named a 2023 Acquia Engage Award winner for its work with INSEAD - The Business School for the World® in the Most Impactful Tech Stack Integration category.
The Acquia Engage Awards recognize organizations that go above and beyond to craft and deliver outstanding digital experiences leveraging the Acquia Open Digital Experience Platform (Acquia Open DXP).
Srijan partnered with INSEAD to revolutionize its digital strategy, improve user engagement, and strengthen its brand identity by building an agile, efficient, and unified digital platform, aligning technology with business strategy to drive growth and success. By utilizing third-party integrations and CDP implementation, Srijan streamlined user journeys with an engaging, cohesive, and effective digital presence.
“INSEAD's success with our tailored solution approach truly exemplifies our commitment to excellence and value,” said Saurabh Das, Chief Delivery Officer for Material. “Being recognized with this award is a testament of our team's relentless focus on delivering impactful solutions that provide unprecedented value for our customers.”
“I appreciate very much the strategic partnership we have with Srijan. It was a very challenging project and Srijan has proven to be a trusted partner, working closely with us in navigating and resolving problems – not only from a technical standpoint but also on a stakeholders management front,” said Choo Tatt Saw, CIO for INSEAD.
Dov Campbell, Director Digital Communications for INSEAD, added: “Our strong collaboration with Srijan enabled us to create a robust, adaptable and seamlessly integrated website that remains true to our initial vision.”
“Our partnership with INSEAD has been dynamic and engaging, where each milestone was met with tailored solutions and a shared commitment to excellence. This award is a testament to that agile and collaborative spirit,” said Rupa Mistry, Delivery Director for Material.
This year’s Engage Awards received hundreds of entries spanning a variety of industries and regions in 26 categories. Each submission was presented to a panel of respected digital experts, who evaluated them on functionality, integration, performance, results, overall user experience, and other criteria. Learn more about how Srijan leveraged Acquia and other tech stacks with the case study here.
About Srijan, A Material Company
Srijan, a Material company, is a global engineering firm that builds transformative digital paths to better futures for a wide range of businesses, from Fortune 500 enterprises to nonprofits worldwide. We bring advanced engineering capabilities and agile practices to some of the biggest names across FMCG, aviation, telecom, technology, and others. Srijan is a Drupal Enterprise Partner & Diamond Certified Contributor and Drupal leader, with 350+ Drupal engineers, and 110+ Acquia certifications.
In 2021, Srijan was acquired by Material, a global strategy partner that combines deep human insights with modern technology – a proprietary science + systems approach that speeds engagement and growth for the world’s most recognizable brands and innovative companies. We design and build customer-centric business models and experiences to create transformative relationships between businesses and the people they serve. For more information visit https://www.materialplus.io/.
About Acquia
Acquia empowers ambitious digital innovators to craft the most productive, frictionless digital experiences that make a difference to their customers, employees, and communities. We provide the world's leading open digital experience platform (DXP), built on open source Drupal, as part of our commitment to shaping a digital future that is safe, accessible, and available to all. With Acquia Open DXP, you can unlock the potential of your customer data and content, accelerating time to market and increasing engagement, conversion, and revenue. Learn more at https://acquia.com.
About INSEAD, The Business School for the World
As one of the world’s leading and largest graduate business schools, INSEAD brings together people, cultures and ideas to develop responsible leaders who transform business and society. Our research, teaching and partnerships reflect this global perspective and cultural diversity.
With locations in Europe (France), Asia (Singapore), the Middle East (Abu Dhabi), and now North America (San Francisco), INSEAD's business education and research spans four regions.
Our 162 renowned Faculty members from 40 countries inspire more than 1,300 degree participants annually in our Master in Management, MBA, Global Executive MBA, Specialized Master’s degrees (Executive Master in Finance and Executive Master in Change) and PhD programmes. In addition, more than 10,000 executives participate in INSEAD Executive Education programmes each year.
INSEAD continues to conduct cutting-edge research and innovate across all our programmes. We provide business leaders with the knowledge and awareness to operate anywhere. Our core values drive academic excellence and serve the global community as The Business School for the World.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231115640758/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient12.1.2026 06:00:00 CET | Press release
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP). The rapid growth of mRNA-based vaccines and therapeutics has driven significant demand for modified nucleotides like m¹ΨTP, which enhances mRNA stability and expression, while reducing immunogenicity. Enginzyme is a deep-tech company delivering optimized biomanufacturing solutions through cell-free enzyme engineering technology. AGC Inc. is a leading global player in fields spanning from architectural glass to chemicals and life science. AGC Inc. provides services in a wide range of life science fields, from synthetic pharmaceuticals and agrochemicals, to biopharmaceuticals and leading-edge cell and gene therapies, as well as messenger RNAs. The presentation in November detailed the latest collaboration between the companies, with a focus on the biomanufacturing of nucleotides for mRNA therapy,
Ant International Partners with Google’s Universal Commerce Protocol to Expand AI Capabilities12.1.2026 02:15:00 CET | Press release
Ant International, a leading global payment, digitisation, and financial technology provider, is collaborating on the launch of Google’s Universal Commerce Protocol (UCP), a new open standard for agentic commerce that works across the entire shopping journey — from discovery and buying to post-purchase support. UCP establishes a common language for agents and systems to operate together across consumer surfaces, businesses, and payment providers to enable commerce. So instead of requiring unique connections for every individual agent, UCP enables all agents to interact easily. UCP is built to work across verticals and is compatible with existing industry protocols like Agent2Agent (A2A), Agent Payments Protocol (AP2), and Model Context Protocol (MCP). “For agentic commerce to scale, it’s critical for the industry to align on a common set of standards. We are proud to have Ant International endorse the Universal Commerce Protocol as the foundation for that future,” said Ashish Gupta, VP
Torq Secures $140M Series D at $1.2B Valuation to Lead the AI SOC and Agentic AI Era11.1.2026 17:59:00 CET | Press release
Fueled by Massive Customer Adoption of AI Agents, Torq Scales the World’s First True AI SOC Platform and Accelerates Expansion into the U.S. Federal Market Torq, the established Agentic AI security operations pioneer, today announced it has closed a massive $140 million Series D funding round, propelling its valuation to $1.2 billion and total funding to $332M. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112510774/en/ Led by Merlin Ventures—a leading cybersecurity fund renowned for its deep access to the U.S. commercial and Public Sector markets—with participation from all existing investors, including Evolution Equity Partners, Notable Capital, Bessemer Venture Partners, Insight Ventures Partners, and Greenfield Partners, this capital injection is a definitive investment in the future of security. Torq is driving the industry’s critical shift: the complete transformation of the Security Operations Center (SOC) through
Andersen udvider sine kompetencer med tilføjelsen af Scimitar9.1.2026 21:44:00 CET | Pressemeddelelse
Andersen Consulting har indgået en samarbejdsaftale med Scimitar, der er et firma med fokus på at accelerere innovation i biovidenskabsbranchen. Scimitar, der har hovedkvarter i USA, et førende konsulenthus inden for strategieksekvering for biovidenskabsbranchen. Virksomheden er specialiseret i design af driftsmodeller, digital transformation og organisatorisk forandring. Scimitar samarbejder med medicinal- og biotech-virksomheder om at accelerere innovation, styrke den driftsmæssige eksekvering og sikre compliance gennem hele produkters livscyklus. Deres praktiske og samarbejdsorienterede tilgang sikrer løsninger, der ikke blot er formålstjenlige, men også skalerbare. "Virksomheder inden for biovidenskabsbranchen befinder sig i en tid med hurtige videnskabelige fremskridt, stigende regulatorisk kompleksitet og et voksende behov for operationel agilitet, samtidig med at de holdes op mod de højeste standarder for patientsikkerhed og dataintegritet," udtaler Ramy Khalil, CEO i Scimitar.
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom